Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Anglo American    AAL   GB00B1XZS820

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

AstraZeneca pain weighs on FTSE, Diageo makes merry after results

share with twitter share with LinkedIn share with facebook
share via e-mail
07/27/2017 | 06:09pm CET
FILE PHOTO: FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield

A punishing fall in AstraZeneca's shares after the failure of a key lung cancer study for the pharma company offset the impact of earnings-led gains for drinks giant Diageo on Britain's top share index.

Britain's FTSE 100 <.FTSE> index fell 0.2 percent on Thursday, in line with the broader European market.

It was a rough day for AstraZeneca (>> AstraZeneca) which lost around $13 billion (10 billion pounds) of its market value as its shares plunged 15.7 percent, its worst day on record.

The healthcare firm's combination of two injectable immunotherapy drugs, durvalumab and tremelimumab, failed to help patients as hoped in a study which was seen as key to proving the value of the group's new drug pipeline.

Analysts at Jefferies estimated that the failure of the study, known as MYSTIC, removed around 10 to 15 percent of mid-term earnings and valuation from the stock.

"With the failure of MYSTIC ... now likely to be fully factored into expectations, the dividend may now look less safe and we expect some investors will start to question its long-term sustainability, despite prior reassurances from management," analysts at Jefferies said in a note.

Wednesday's decision by the U.S. Federal Reserve to keep interest rates on hold was also weighing on the internationally-exposed FTSE, with banking stocks coming under pressure.

"The general interpretation from the Fed meeting in Europe has been that it's sending the euro and the pound higher, which is not good for our exporters," said Jasper Lawler, senior market analyst at London Capital Group.

"That environment probably exacerbated the fall we are seeing in Astra and some of the other shares as well."

It was better news for mid cap pharma stock Indivior (>> Indivior), whose shares surged 17.6 percent to the top of the European index after it reported first-quarter earnings, with Jefferies analysts highlighting a boost to the firm's operating leverage from a stronger U.S. market. [nL3N1KI30Z]

An earnings update also boosted shares in distilled drinks company Diageo (>> Diageo), which jumped 5.7 percent to an all-time high after raising its profitability target and announcing a share buyback programme.

Likewise pest control company Rentokil Initial (>> Rentokil Initial) gained 5.7 percent after reporting half-year results.

News that miner Anglo American (>> Anglo American) would resume dividend payments six months early helped its shares add around 3 percent.

The miner was forced to suspend its dividend during the commodity rout in 2015, but was helped by a rise in commodities prices last year as well as by cost-cutting measures.

Among mid-caps Acacia Mining (>> Acacia Mining PLC) jumped 15 percent, its best day in 13 months after a seven-day losing streak. Its parent company Barrick Gold (>> Barrick Gold Corp), the world's largest gold miner by production, said it would start talks with the Tanzanian government next week about an export ban which has helped wipe two-thirds of the stock's market value since it was announced in March.

(Reporting by Kit Rees; Editing by Keith Weir and Pritha Sarkar)

By Kit Rees and Helen Reid

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ANGLO AMERICAN
12/14 ANGLO AMERICAN : rough diamond sales value for De Beers' tenth sales cycle of 20..
12/12DJANGLO AMERICAN : De Beers Diamond Sales Down 3.4%
12/12 ANGLO AMERICAN : De Beers rough diamond sales Cycle 10, 2017
12/06 ELECTRIC CHARGE : Glencore bets big on car battery metals
12/05 FTSE slips on recovering sterling, cyclical falls
12/04DJRio Tinto Elevates Director to Chairman -- WSJ
12/04 Rio Tinto holds course as it looks inward for new chairman
12/04 Rio Tinto holds course as it looks inward for new chairman
12/01 ANGLO AMERICAN : Robots will run mines within the next decade, Anglo says
12/01 ANGLO AMERICAN : Robots will run mines within the next decade, Anglo says
More news
News from SeekingAlpha
12/04 FT : De Beers to invest in blockchain-based diamond platform
12/04 Iron ore surges back to bull market as China's output cuts boost prices
11/29 Iron ore seen sinking back to $50/ton at Goldman Sachs
11/26 THE NEST EGG PORTFOLIO : Should You Be Worried About A BT Group Dividend Cut?
11/20 Anglo to shut Minas Rio if expansion license remains delayed
Financials ($)
Sales 2017 25 831 M
EBIT 2017 6 003 M
Net income 2017 3 133 M
Debt 2017 5 452 M
Yield 2017 5,38%
P/E ratio 2017 7,78
P/E ratio 2018 9,03
EV / Sales 2017 1,22x
EV / Sales 2018 1,20x
Capitalization 26 169 M
Duration : Period :
Anglo American Technical Analysis Chart | AAL | GB00B1XZS820 | 4-Traders
Technical analysis trends ANGLO AMERICAN
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 25
Average target price 19,8 $
Spread / Average Target 6,4%
EPS Revisions
Mark Cutifani Chief Executive Officer & Executive Director
Stuart John Chambers Chairman
Stephen Thomas Pearce Executive Director & Finance Director
Anthony Martin O'Neill Director & Technical Director
Philip Roy Hampton Senior Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ANGLO AMERICAN19.18%26 169
BHP BILLITON PLC2.68%106 125
RIO TINTO9.81%85 794
GRUPO MEXICO S.A. DE C.V.4.45%24 649